IDERA PHARMACEUTICALS INC - COM NEW (IDRA)

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM NEW
Total 13F shares
48,362,393
Share change
-11,663,572
Total reported value
$162,006,382
Put/Call ratio
81%
Price per share
$3.35
Number of holders
81
Value change
-$39,803,408
Number of buys
33
Number of sells
43

Institutional Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q3 2015

As of 30 Sep 2015, IDERA PHARMACEUTICALS INC - COM NEW (IDRA) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 48,362,393 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, PUTNAM INVESTMENTS LLC, Broadfin Capital, LLC, VANGUARD GROUP INC, NATIXIS, BlackRock Fund Advisors, JENNISON ASSOCIATES LLC, BlackRock Institutional Trust Company, N.A., DEUTSCHE BANK AG\, and JPMORGAN CHASE & CO. This page lists 81 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.